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Background
Glycosylation is a key post-translational modification that
can affect critical properties of proteins produced in bio-
pharmaceutical manufacturing, such as stability, thera-
peutic efficacy or immunogenicity. However, unlike a
protein’s amino acid sequence, glycosylation is hard to
engineer since it does not follow any direct equivalent of
a genetic code. Instead, its complex biogenesis in the
Golgi apparatus (Figure 1A) integrates a variety of influ-
encing factors most of which are only incompletely
understood. Various attempts have been undertaken so
far to computationally model the process of glycosylation,
but due to the high parametric demand of most of these
models, it has been challenging to leverage these models
for glycoengineering purposes. Consequently, industrial
glycoengineering is still largely carried out using costly
and time-consuming trial-and-error strategies and could
greatly benefit from computational models that would
better meet the requirements for industrial utilization.
Here, we introduce a novel approach combining con-
straints-based and stochastic techniques to derive a com-
putational model that can predict the effects of gene
knockouts on protein glycoprofiles while requiring only
minimal a-priori parameter input.
Computational approach
We use the COBRA toolbox to generate an in-silico
representation of the N-glycosylation network. The sto-
chastic transition of glycans through this reaction net-
work is modeled as a Markov chain where secreted
glycans are represented as absorbing states (Figure 1B,C).
After the user has submitted an experimentally derived
glycoprofile on a specific protein (for instance, obtained
from a cell culture grown under standard conditions,
Figure 1C), sampling methods are used to deduce the
unknown probabilities of transitioning from one glycan
to another in the network. These transition probabilities
are concisely assembled in a Markov transition matrix
(Figure. 1D). After this fitting procedure, enzyme knock-
outs are modelled by setting particular transition prob-
abilities to zero and adjusting the remaining probabilities
through optimization (Figure 1E).
Results
Our model is capable of creating N-glycosylation reac-
tion networks that are complex enough to cover typical
glycoprofiles found in biopharmaceutical manufacturing
including tetra-antennary, highly sialylated or polylacto-
samine carrying glycans. The probabilistic framework
implemented in this model proves to outperform knock-
out predictions derived from pure constraints-based
modeling. Tests on experimental knockout glycoprofiles
both from the literature and our laboratory show that
the model yields sound predictions of glycoprofile
change upon genetic modification which are in good
congruence with corresponding experiments (Figure 1F).
Conclusion and outlook
The model has the potential to provide a cheap and fast
guidance tool to help find host conditions that can yield a
desired glycoprofile, thus providing an important step
towards the in-silico process of glycoengineering. So far,
the reaction network considered is specific for CHO cells
but can be easily modified to include reactions occurring
in other hosts. In addition, it could be integrated into
whole-cell metabolic models. This would enable compre-
hensive in-silico representations of the entire cell-culture
setup, allowing one to simulate the effects on the1Department of Bioengineering, University of California, San Diego, La Jolla,
CA 92093, USA
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Figure 1 (a)Glycosylation is the outcome of a complex reaction network where the glycoprotein is successively processed by several
enzymes in a sequence of Golgi compartments.(b)In the model glycosylation is conceptualized as a random walk (Markov chain) starting in
the initial Man9GlcNAc2 glycan and reaching a certain secreted glycan with a certain secretion probability. (c) Secreted glycans are modelled as
absorbing states of the Markov chain that transition to themselves with probability 1, once they have been reached. To fit the unknown
transition probabilities, the user inputs the experimentally derived glycoprofile of the protein of interest. (d) The deduced transition probabilities
are arranged in a Markov transition matrix that gives the probabilities of transitioning from any glycan (rows) to any other (columns). (e)To
model an enzyme knockout, the corresponding transition probability is set to 0. Optimization is used to adjust the alternative transition
probabilities to maintain a probability sum of 1 for every glycan affected by the knockout. (f)Wildtype and Fut8 knockout glycoprofile of CHO-S
secretome (black bars), together with the glycan frequencies as predicted by the model (red bars).
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glycoprofile of a wide range of both intracellular and extra-
cellular modifications to the growth conditions.
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